Answers are grounded in this paper and cite their sources.
These results confirmed the clinical safety, performance, and benefits of an innovative active transcutaneous bone conduction implant with a piezoelectric transducer design for patients with CHL, MHL, or SSD.
No takes yet. Share an insight, caveat, or question.
Ordóñez et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: